Home » Advanced Oncotherapy (AVO) » Nicolas Serandour, CEO of Advanced Oncotherapy #AVO talks to Andrew Scott at Proactive Investors

Nicolas Serandour, CEO of Advanced Oncotherapy #AVO talks to Andrew Scott at Proactive Investors

By in Advanced Oncotherapy (AVO) on .

Nicolas Serandour, CEO of Advanced Oncotherapy #AVO, visited the Proactive Investors studio to add some extra detail to their recent announcement that they’ve secured £37.4mln of fresh funding – £30mln of this coming from a new Chinese investor.

Tags: , , , , , , ,

Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.